Account
News
15.12.2022
PMA Insights: Week 50

We summarise four handpicked articles from pharmaceutical, pricing and market access that are worth ...

Read more
Articles
14.12.2022
2022 Review: Effective P & R Processes to Ens...

We discuss gene therapy pricing and reimbursement, manufacturing methods, analytical analysis, and k...

Read more
Webinar
08.12.2022
Are you ready for the new EU HTA in 2025?

Webinar: Our experts discuss the latest news and updates on the EU HTA process, including the Joint ...

Read more
Insider Insights
06.12.2022
UK NHS England set to eliminate hepatitis C by 203...

NHS England has reported that following a 5-year £1b antiviral drugs deal, deaths from Hepatitis C ...

Read more
Insider Insights
06.12.2022
France – Clinical trials: an improved 2021 but t...

France have improved the conduction of clinical trials in 2021, due to the reduction of regulatory d...

Read more
30.11.2022
Reflecting on the Pricing & Market Access tren...

Our experts reflect on the trends that shaped the European pricing and market access landscape in 20...

Read more
News
16.11.2022
PMA Insights: Week 46 SPECIAL EDITION ISPOR 2022 R...

We summarise the ISPOR Europe 2022 conference including plenary sessions on HTA, patient-centered re...

Read more
Publications
09.11.2022
ISPOR 2022 Plenary Session 3 - Integrating Data

Our experts provide a detailed summary of Plenary Session 2 at ISPOR 2022 on innovative methods for ...

Read more
Publications
08.11.2022
ISPOR 2022 Plenary Session 2 - Real-World Research

Introduction Real World Data is being increasingly used across the globe to support medical-product ...

Read more
Publications
07.11.2022
ISPOR 2022 Plenary Session 1 - HTA and Regulation

Our experts provide a detailed summary of Plenary Session 1 at ISPOR 2022 on the Convergence of HTA ...

Read more

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.